Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
INTERFERON alpha2 (IFN alpha2) as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration: a pilot study
The aim of this study is to examine the action of Interferon 2 as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
Role of immunosuppression with steroids in the outcome of fibrosis due to recurrent hepatitis C virus (HCV) infection after liver transplantation
To assess its histological severity of the fibrosis induced by hepatitis C recurrence after liver transplantation and to correlate it with two different schedules of steroid treatment employed as part...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
Evaluation of the role of 18F-di-idrossi-fenil-alanina 18F-DOPA in images diagnostic by Positron Emission Tomography PET in study of human neuroendocrin neoplasia
- to allow earlier diagnosis of the neural crest derivation neoplasie; - more accurate evaluation of primitive neoplasia extension, of eventual secondary lesions presence and of the therapy answer; ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
TOLLERANZA ED EFFICACIA DELL?a-TOCOFEROLO SUCCINATO NEL TRATTAMENTO DI PAZIENTI IN ETA? PEDIATRICA AFFETTI DA EPATITE CRONICA HBsAg POSITIVA
efficacia e tollerabilita' del trattamento con vitamina E in bambini affetti da epatite cronica HBsAg./HBeAg positivi
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients
1. Comparison between study groups of the incidence and severity of histologically-proven rejection episodes. 2. Comparison between study groups of the incidence and severity of histologically-proven ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
Use of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosis STUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008
To evaluate the sensitivity of 68Ga-DOTA-NOC PET/CT for the assessment of Idiopathic Pulmonary Fibrosis patients, in particular IPF and NSIP cases, comparing PET/CT results with data obtained with rou...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
Plerixafor MM02 - Plerixafor plus G-CSF after chemotherapy for the mobilization of Peripheral Blood Stem Cells (PBSCs) in Multiple Myeloma (MM) patients undergoing Autologous Stem Cell Transplantation (ASCT) Plerixafor in associazione al fattore di crescita granulocitario (G-CSF) dopo chemioterapia per la mobilizzazione di cellule staminali nel sangue periferico (PBSCs) in pazienti con mieloma multiplo (MM) candidati a trapianto di cellule staminali autologhe (ASCT)
Percentage of patients collecting ≥ 6 x 106 CD34+ cells/Kg in three or less apheresis Percentuale di pazienti in grado di raccogliere ≥ 6 x 106 cellule CD34+ /Kg in tre o meno di tre procedu...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
OPEN LABEL, PHASE II PILOT STUDY OF STI571 IN THE TREATMENT OF PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA PTCL REFRACTORY, RESISTANT OR NOT AMENABLE TO CONVENTIONAL THERAPY
- Assessment of safety and tolerability of imatinib mesylate 400 mg bid in the clinical setting of peripheral T-cell lymphomas PTCL ; - Assessment of clinical responses defined as disease stabiliza...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
INTRATHECAL LEVOBUPIVACAINE USE IN CESAREAN SECTION : DETERMINATION OF �MINIMUM LOCAL ANESTHETIC DOSE (MLAD)�
To detect the most appropriate local anesthetic dose that results in effective subarachnoidal anesthesia in cesarean section , Levobupivacaine, for both surgical purpose and patient`s �comfort anesth...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
non disponibile
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
3
4
5
6
7
8
9
10
11
12
Suivant